263 related articles for article (PubMed ID: 2522917)
21. Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
Taghian A; Lespinasse F; Guichard ME
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1535-40. PubMed ID: 1834621
[TBL] [Abstract][Full Text] [Related]
22. Radiosensitization by misonidazole, pimonidazole and azomycin and intracellular uptake in human tumour cell lines.
Watts ME; Dennis MF; Roberts IJ
Int J Radiat Biol; 1990 Feb; 57(2):361-72. PubMed ID: 1968500
[TBL] [Abstract][Full Text] [Related]
23. Modulation of X ray DNA damage by SR-2508 +/- buthionine sulfoximine.
Kinsella TJ; Dobson PP; Russo A; Mitchell JB; Fornace AJ
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1127-30. PubMed ID: 2943711
[TBL] [Abstract][Full Text] [Related]
24. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
Clark EP; Epp ER; Biaglow JE; Morse-Gaudio M; Zachgo E
Radiat Res; 1984 May; 98(2):370-80. PubMed ID: 6539482
[TBL] [Abstract][Full Text] [Related]
25. The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers.
Shrieve DC; Harris JW
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jul; 48(1):127-38. PubMed ID: 3159699
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
Brown DM; Dionet C; Brown JM
Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
[TBL] [Abstract][Full Text] [Related]
27. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
Newman HF; Bleehen NM; Ward R; Workman P
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):677-84. PubMed ID: 2843488
[TBL] [Abstract][Full Text] [Related]
28. [Present status of hypoxic cell sensitizers and PLDR inhibitors].
Ono K; Sasai K; Shibamoto Y; Tsutsui K; Fushiki M; Nishidai T; Takahashi M; Abe M
Gan No Rinsho; 1987 Oct; 33(13):1673-8. PubMed ID: 2961900
[TBL] [Abstract][Full Text] [Related]
29. Radiosensitizing and cytotoxic effects of nitroimidazoles in CHO cells expressing elevated levels of glutathione-S-transferase.
Stratford IJ; Hickson ID; Robson CN; Stephens M
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1307-10. PubMed ID: 2523884
[TBL] [Abstract][Full Text] [Related]
30. [Radiosensitizer: hypoxic cell radiosensitizer].
Mori T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
[TBL] [Abstract][Full Text] [Related]
31. Combined effect of misonidazole and glutathione depletion by buthionine sulphoximine on cellular radiation response.
Edgren M; Nishidai T; Scott OC; Révész L
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Apr; 47(4):463-74. PubMed ID: 3872859
[TBL] [Abstract][Full Text] [Related]
32. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.
Sasai K; Shibamoto Y; Takahashi M; Zhou L; Hori H; Nagasawa H; Shibata T; Inayama S; Abe M
Cancer Chemother Pharmacol; 1990; 26(2):112-6. PubMed ID: 2140730
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the cytological effects of three hypoxic cell radiosensitizers.
Spunberg JJ; Geard CR; Rutledge-Freeman MH
Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1207-15. PubMed ID: 6214532
[TBL] [Abstract][Full Text] [Related]
34. [Recent advances in hypoxic cell radiosensitizer].
Ono K; Takahashi M; Nishidai T; Shibamoto Y; Abe M
Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470
[TBL] [Abstract][Full Text] [Related]
35. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
Mitchell JB; Russo A; Biaglow JE; McPherson S
Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
[TBL] [Abstract][Full Text] [Related]
36. Glutathione requirement for the rejoining of radiation-induced DNA breaks in misonidazole-treated cells.
Edgren M; Révész L
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Aug; 48(2):207-12. PubMed ID: 3874842
[TBL] [Abstract][Full Text] [Related]
37. Hypoxic cell radiosensitizers: expectations and progress in drug development.
Coleman CN
Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):323-9. PubMed ID: 3156109
[TBL] [Abstract][Full Text] [Related]
38. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
[TBL] [Abstract][Full Text] [Related]
39. Protection against light-activated photofrin II killing of tumor cells by nitroimidazoles.
Santus R; Stobbe CC; McPhee MS; Chapman JD
Radiat Res; 1992 Apr; 130(1):31-7. PubMed ID: 1532856
[TBL] [Abstract][Full Text] [Related]
40. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
Jenner TJ; O'Neill P; Crump PW; Fielden EM; Sapora O; Santodonato L
Biochem Pharmacol; 1991 Oct; 42(9):1705-10. PubMed ID: 1930296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
